
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2025 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2025 Earnings Call Transcript May 7, 2025 Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $0.52, expectations were $0.47. Operator: Hello, and welcome to the Q1 2025 …